Published December 28, 2025 | Version v1

Effect of Digoxin on clusters of circulating tumor cells in patients with metastatic breast cancer: a phase 1 trial

  • 1. ROR icon ETH Zurich
  • 2. ROR icon University Hospital Zurich

Description

This repository contains processed transcriptomics data, large data sets and additional files required to reproduce the code available at the repository https://github.com/TheAcetoLab/dicct-trial

Notes

This work is supported by the European Research Council (101001652), the strategic focus area of personalized health and related technologies at ETH Zurich (PHRT-541), the Swiss National Science Foundation (212183), the Swiss Cancer League (KLS-5636-08-2022), the ETH Lymphoma Challenge (LC-02-22) and ETH Zurich.

Files

Files (17.8 MB)

Name Size Download all
md5:330789a886d9a5dd26c431cf3b223887
607.0 kB Download
md5:8373aa555e32b7ba586d9f3e2fb97c9c
10.5 MB Download
md5:c839f32f501690ba386c7f605d511f40
6.7 MB Download

Additional details

Funding

European Commission
TUMOR-LOCK - Tumor-lock: forbid the generation of circulating tumor cells 101001652